Preliminary reports indicate conolidine may possibly inhibit certain ion channels, cutting down neuronal excitability and limiting agony alerts. This system is particularly relevant in neuropathic discomfort, exactly where abnormal signaling triggers persistent pain. Moreover, conolidine seems to influence G protein-coupled receptor (GPCR) pathways